Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3534) 3534
Newsletter (54) 54
Dissertation (27) 27
Book Chapter (13) 13
Conference Proceeding (4) 4
Newspaper Article (3) 3
Publication (3) 3
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2603) 2603
life sciences & biomedicine (2380) 2380
humans (1979) 1979
microbiology (1670) 1670
infectious diseases (1480) 1480
klebsiella pneumoniae (1231) 1231
klebsiella pneumoniae - drug effects (1205) 1205
anti-bacterial agents - pharmacology (1090) 1090
klebsiella infections - microbiology (1066) 1066
klebsiella (1059) 1059
klebsiella pneumoniae - isolation & purification (1053) 1053
klebsiella pneumoniae - genetics (1022) 1022
microbial sensitivity tests (985) 985
beta-lactamases - genetics (932) 932
klebsiella pneumoniae - enzymology (868) 868
pharmacology & pharmacy (841) 841
pneumonia (814) 814
antibiotics (783) 783
drug resistance (783) 783
male (739) 739
bacteria (677) 677
female (676) 676
carbapenemase (657) 657
bacterial pneumonia (650) 650
bacterial proteins - genetics (603) 603
beta-lactamases - metabolism (569) 569
klebsiella infections - epidemiology (557) 557
hospitals (520) 520
middle aged (513) 513
klebsiella infections - drug therapy (499) 499
carbapenems - pharmacology (495) 495
aged (475) 475
antimicrobial agents (462) 462
infections (462) 462
epidemiology (446) 446
e coli (445) 445
health aspects (427) 427
biochemical phenomena, metabolism, and nutrition (409) 409
anti-bacterial agents - therapeutic use (408) 408
drug resistance in microorganisms (404) 404
genes (399) 399
adult (392) 392
bacterial proteins - metabolism (377) 377
research (367) 367
biological and medical sciences (360) 360
plasmids (357) 357
bacterial infections and mycoses (356) 356
medicine (345) 345
polymerase chain reaction (333) 333
antibiotic resistance (309) 309
carbapenems (304) 304
multilocus sequence typing (303) 303
medical sciences (298) 298
drug resistance, bacterial (295) 295
risk factors (293) 293
polycyclic compounds (291) 291
antimicrobial resistance (276) 276
beta-lactamases - biosynthesis (276) 276
beta lactamases (275) 275
enterobacteriaceae (274) 274
drug resistance, multiple, bacterial (273) 273
nosocomial infections (273) 273
infectious disease (271) 271
research article (265) 265
aged, 80 and over (264) 264
analysis (263) 263
mortality (256) 256
klebsiella pneumoniae - classification (251) 251
pathogens (251) 251
escherichia coli (250) 250
laboratories (242) 242
cross infection - microbiology (240) 240
immunology (231) 231
patients (221) 221
gram-negative bacteria (216) 216
escherichia coli - drug effects (214) 214
beta-lactam resistance (205) 205
antibiotics. antiinfectious agents. antiparasitic agents (202) 202
drug resistance, multiple, bacterial - genetics (202) 202
colistin (196) 196
genotype (190) 190
escherichia coli - genetics (186) 186
public health (184) 184
enterobacteriaceae infections - microbiology (181) 181
animals (179) 179
pharmacology. drug treatments (177) 177
science & technology - other topics (170) 170
escherichia coli - isolation & purification (169) 169
plasmids - genetics (169) 169
multidisciplinary sciences (168) 168
bacterial proteins - biosynthesis (167) 167
infectious and parasitic diseases (163) 163
electrophoresis, gel, pulsed-field (162) 162
bacteriology (160) 160
cross infection - epidemiology (160) 160
antibacterial agents (158) 158
dna, bacterial - genetics (157) 157
bacterial infections (151) 151
disease outbreaks (151) 151
science (150) 150
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3546) 3546
Portuguese (72) 72
Spanish (68) 68
Russian (14) 14
German (13) 13
Turkish (11) 11
French (10) 10
Chinese (9) 9
Japanese (7) 7
Korean (4) 4
Dutch (3) 3
Croatian (2) 2
Norwegian (2) 2
Persian (2) 2
Polish (2) 2
Arabic (1) 1
Czech (1) 1
Danish (1) 1
Italian (1) 1
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase—Producing K. pneumoniae: Importance of Combination Therapy
by Mario Tumbarello and Pierluigi Viale and Claudio Viscoli and Enrico Maria Trecarichi and Fabio Tumietto and Anna Marchese and Teresa Spanu and Simone Ambretti and Francesca Ginocchio and Francesco Cristini and Angela Raffaella Losito and Sara Tedeschi and Roberto Cauda and Matteo Bassetti
Clinical infectious diseases, ISSN 1058-4838, 10/2012, Volume 55, Issue 7, pp. 943 - 950
Health outcomes | Microbial sensitivity tests | Infectious diseases | Antimicrobials | Mortality | Septic shock | Infections | ARTICLES AND COMMENTARIES | Carbapenems | Klebsiella pneumoniae | Blood | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Bacterial diseases | Human bacterial diseases | Bacterial sepsis | Klebsiella pneumoniae - isolation & purification | Prognosis | Humans | Middle Aged | Bacteremia - mortality | Male | Bacterial Proteins - secretion | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Retrospective Studies | Severity of Illness Index | Risk Factors | Decision Support Techniques | Bacteremia - diagnosis | Klebsiella Infections - microbiology | beta-Lactamases - secretion | Drug Therapy, Combination - methods | Klebsiella pneumoniae - enzymology | Survival Analysis | Klebsiella Infections - diagnosis | Italy | Klebsiella Infections - mortality | Aged | Cohort Studies | Klebsiella infections | Blood-borne diseases | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Bacterial infections | Gram-negative bacteria | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
by Grundmann, Hajo, Prof and Glasner, Corinna, PhD and Albiger, Barbara, PhD and Aanensen, David M, PhD and Tomlinson, Chris T, PhD and Andrasević, Arjana Tambić, Prof and Cantón, Rafael, Prof and Carmeli, Yehuda, Prof and Friedrich, Alexander W, Prof and Giske, Christian G, MD and Glupczynski, Youri, Prof and Gniadkowski, Marek, Prof and Livermore, David M, Prof and Nordmann, Patrice, Prof and Poirel, Laurent, PhD and Rossolini, Gian M, Prof and Seifert, Harald, Prof and Vatopoulos, Alkiviadis, Prof and Walsh, Timothy, Prof and Woodford, Neil, Prof and Monnet, Dominique L, PhD and European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group and European Survey Carbapenemase-Prod
The Lancet infectious diseases, ISSN 1473-3099, 2016, Volume 17, Issue 2, pp. 153 - 163
Infectious Disease | RESISTANCE | HOSPITALS | KPC-3 | OUTBREAK | SUSCEPTIBILITY | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Klebsiella pneumoniae - isolation & purification | Escherichia coli - enzymology | Prevalence | Prospective Studies | Europe | Humans | Escherichia coli Infections - microbiology | Klebsiella Infections - microbiology | Bacterial Proteins | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Klebsiella Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Klebsiella pneumoniae - enzymology | Klebsiella pneumoniae - genetics | beta-Lactamases | Surveys and Questionnaires | Anti-Bacterial Agents - pharmacology | Surveys | Pneumonia | Bacterial pneumonia | Escherichia coli | Genomics | Cross infection | Nosocomial infections | Epidemiology | Studies | Quality standards | Surveillance | Antibiotics | E coli | Laboratories | Population | Infections | Drug resistance | Patients | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Colistin-Resistant, Klebsiella pneumoniae Carbapenemase (KPC)—Producing Klebsiella pneumoniae Belonging to the International Epidemic Clone ST258
by Tatiana Bogdanovich and Jennifer M. Adams-Haduch and Guo-Bao Tian and Minh Hong Nguyen and Eun Jeong Kwak and Carlene A. Muto and Yohei Doi
Clinical infectious diseases, ISSN 1058-4838, 8/2011, Volume 53, Issue 4, pp. 373 - 376
BRIEF REPORT | Epidemics | Intensive care units | Infectious diseases | Disease transmission | Infections | Klebsiella pneumoniae | Labor standards | Inoculum | Polymyxins | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Humans | Klebsiella Infections - microbiology | beta-Lactamases - biosynthesis | Microbial Sensitivity Tests | Klebsiella Infections - epidemiology | beta-Lactams - pharmacology | Colistin - pharmacology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Klebsiella pneumoniae - enzymology | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - biosynthesis | Complications and side effects | Drug resistance in microorganisms | Klebsiella infections | Colistin | Distribution | Reports | Genetic aspects | Bacterial infections | Drug resistance | Cloning | Index Medicus | Brief Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Outbreak of Klebsiella pneumoniae carbapenemase–producing K pneumoniae : A systematic review
by Campos, Anaelís C., MSc and Albiero, James, MSc and Ecker, Alessandra B., MSc and Kuroda, Cristina M., MSc and Meirelles, Lívia E.F and Polato, Angelita, PhD and Tognim, Maria C.B., PhD and Wingeter, Márcia A., MSc and Teixeira, Jorge J.V., PhD
American journal of infection control, ISSN 0196-6553, 2016, Volume 44, Issue 11, pp. 1374 - 1380
Infectious Disease | Infection Control | Klebsiella pneumoniae carbapenemase | carbapenems | disease outbreaks | infection control | Klebsiella pneumoniae | Public, Environmental & Occupational Health | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Klebsiella pneumoniae - isolation & purification | Klebsiella Infections - prevention & control | Global Health | Cross Infection - prevention & control | Humans | Bacterial Proteins - secretion | Klebsiella Infections - microbiology | Infection Control - methods | beta-Lactamases - secretion | Disease Transmission, Infectious - prevention & control | Klebsiella Infections - epidemiology | Disease Outbreaks | Cross Infection - microbiology | Klebsiella pneumoniae - enzymology | Cross Infection - epidemiology | Health aspects | Pneumonia | Bacterial pneumonia | Epidemics | Systematic review | Bacterial infections | Gram-negative bacteria | Disease control | Meta-analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
by Maria Souli and Irene Galani and Anastasia Antoniadou and Evangelos Papadomichelakis and Garyphallia Poulakou and Theofano Panagea and Sofia Vourli and Loukia Zerva and Apostolos Armaganidis and Kyriaki Kanellakopoulou and Helen Giamarellou
Clinical infectious diseases, ISSN 1058-4838, 2/2010, Volume 50, Issue 3, pp. 364 - 373
Intensive care units | Health outcomes | Microbial sensitivity tests | Antimicrobials | Hospital admissions | Hospital units | Infections | ARTICLES AND COMMENTARIES | Carbapenems | Klebsiella pneumoniae | Bacteremia | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Klebsiella pneumoniae - isolation & purification | beta-Lactam Resistance | DNA Fingerprinting | Humans | Middle Aged | Male | Klebsiella pneumoniae - classification | beta-Lactamases - biosynthesis | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Disease Outbreaks | Bacterial Typing Techniques | Aged, 80 and over | Adult | Female | Intensive Care Units | Klebsiella Infections - drug therapy | Hospitals, University | Treatment Outcome | Greece - epidemiology | Klebsiella Infections - microbiology | Electrophoresis, Gel, Pulsed-Field | Molecular Epidemiology | Klebsiella pneumoniae - enzymology | Aged | Bacterial Proteins - biosynthesis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae
by Falcone, M and Russo, A and Iacovelli, A and Restuccia, G and Ceccarelli, G and Giordano, A and Farcomeni, A and Morelli, A and Venditti, M
Clinical microbiology and infection, ISSN 1198-743X, 05/2016, Volume 22, Issue 5, pp. 444 - 450
carbapenem-resistant Klebsiella pneumoniae strain | septic shock | KPC-Kp | Adequate source control | colistin-resistance | Septic shock | Colistin-resistance | Carbapenem-resistant Klebsiella pneumoniae strain | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Prognosis | Humans | Middle Aged | Male | Bacterial Proteins - secretion | Anti-Bacterial Agents - therapeutic use | Hospitals, Teaching | Shock, Septic - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Intensive Care Units | Klebsiella Infections - drug therapy | Treatment Outcome | Klebsiella Infections - microbiology | Shock, Septic - mortality | beta-Lactamases - secretion | Shock, Septic - microbiology | Adolescent | Klebsiella pneumoniae - enzymology | Survival Analysis | Klebsiella Infections - mortality | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase—Producing K. pneumoniae
by Elizabeth B. Hirsch and Beining Guo and Kai-Tai Chang and Henry Cao and Kimberly R. Ledesma and Manisha Singh and Vincent H. Tam
The Journal of infectious diseases, ISSN 0022-1899, 3/2013, Volume 207, Issue 5, pp. 786 - 793
Killing | Lungs | MAJOR ARTICLES AND BRIEF REPORTS | Antimicrobials | Drug interactions | Infections | Drug design | Mice | Dosage | Carbapenems | Klebsiella pneumoniae | AmpC | synergism | beta-lactamases | combined killing | pharmacodynamics | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Biological and medical sciences | Medical sciences | Bacteriology | Lung - microbiology | Klebsiella pneumoniae - isolation & purification | Pneumonia, Bacterial - microbiology | Klebsiella Infections - drug therapy | Klebsiella pneumoniae - drug effects | Microbial Viability - drug effects | Humans | Treatment Outcome | Bacterial Load | Bacterial Proteins - secretion | Klebsiella Infections - microbiology | beta-Lactamases - secretion | Microbial Sensitivity Tests | Drug Therapy, Combination - methods | Animals | Klebsiella pneumoniae - enzymology | Female | Pneumonia, Bacterial - drug therapy | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Disease Models, Animal | Klebsiella infections | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Antibacterial agents | Drug synergism | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Emergence and Rapid Regional Spread of Klebsiella pneumoniae Carbapenemase—Producing Enterobacteriaceae
by Sarah Y. Won and L. Silvia Munoz-Price and Karen Lolans and Bala Hota and Robert A. Weinstein and Mary K. Hayden and Ctr Dis Control & Prevention Epict and Centers for Disease Control and Prevention Epicenter Program and for the Centers for Disease Control and Prevention Epicenter Program
Clinical infectious diseases, ISSN 1058-4838, 9/2011, Volume 53, Issue 6, pp. 532 - 540
Polymerase chain reaction | Nursing homes | Network analysis | Hospital admissions | Bacteria | Infections | Patient surveillance | Health care facilities | ARTICLES AND COMMENTARIES | Klebsiella pneumoniae | Enterobacteriaceae | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Humans | Middle Aged | Male | Multilocus Sequence Typing | beta-Lactamases - biosynthesis | Cross Infection - transmission | Indiana - epidemiology | Klebsiella Infections - epidemiology | Disease Outbreaks | Bacterial Typing Techniques | Drug Resistance, Multiple, Bacterial | Klebsiella pneumoniae - genetics | Aged, 80 and over | Female | Klebsiella Infections - transmission | Cross Infection - epidemiology | Klebsiella Infections - drug therapy | Klebsiella Infections - microbiology | Cross Infection - drug therapy | Contact Tracing | Illinois - epidemiology | Molecular Epidemiology | Cross Infection - microbiology | Klebsiella pneumoniae - enzymology | Aged | Bacterial Proteins - biosynthesis | Klebsiella infections | Enterobacteriaceae infections | Cross infection | Research | Nosocomial infections | Distribution | Epidemics | Hospitalization | Gram-negative bacteria | Drug resistance | Epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase—Producing K. pneumoniae in Intensive Care Unit
by Francesco Sbrana and Paolo Malacarne and Bruno Viaggi and Sergio Costanzo and Piero Leonetti and Alessandro Leonildi and Beatrice Casini and Carlo Tascini and Francesco Menichetti
Clinical infectious diseases, ISSN 1058-4838, 3/2013, Volume 56, Issue 5, pp. 697 - 700
Intensive care units | Antibiotics | Antimicrobials | Mortality | Sepsis | Septic shock | Urinary tract infections | Infections | Carbapenems | Klebsiella pneumoniae | BRIEF REPORTS | intensive care unit | outcome | KPC-producing Klebsiella pneumoniae | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Intensive Care Units | Klebsiella Infections - drug therapy | Gentamicins - therapeutic use | Humans | Middle Aged | Minocycline - analogs & derivatives | Male | Treatment Outcome | Klebsiella Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Minocycline - therapeutic use | Klebsiella pneumoniae - enzymology | Adult | Bacterial Proteins - metabolism | Colistin - therapeutic use | Female | Aged | Retrospective Studies | beta-Lactamases - metabolism | Drug Therapy, Combination | Klebsiella | Pneumonia | Critically ill | Bacterial pneumonia | Drug therapy | Health aspects | Intensive care | Gram-negative bacteria | Nosocomial infections | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
by Daikos, G.L and Markogiannakis, A
Clinical microbiology and infection, ISSN 1198-743X, 08/2011, Volume 17, Issue 8, pp. 1135 - 1141
carbapenems | Klebsiella pneumoniae | Carbapenemases | KPC and VIM β-lactamases | therapeutic efficacy | KPC and VIM β‐lactamases | Therapeutic efficacy | Carbapenems | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella Infections - drug therapy | Klebsiella pneumoniae - drug effects | Humans | Treatment Outcome | Klebsiella Infections - microbiology | beta-Lactamases - biosynthesis | Anti-Bacterial Agents - therapeutic use | Animals | Carbapenems - pharmacology | Microbial Sensitivity Tests - standards | Carbapenems - therapeutic use | Klebsiella pneumoniae - enzymology | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - biosynthesis | Mice | Drug Therapy, Combination | Beta lactamases | Pneumonia | Drug resistance | Bacterial pneumonia | Drug therapy | Infections | Index Medicus | Drugs | Infection | Breakpoints | Pharmacodynamics | Antibiotics | Decision making | Minimum inhibitory concentration | Data processing | Pharmacokinetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights